MNKD Stock Analysis: Buy, Sell, or Hold?
MNKD - Mannkind Corporation
$4.14
0.21 (5.34%)
▲
5d:
+5.08%
30d:
+16.62%
90d:
+80.0%
BUY
MODERATE Confidence
Analysis Updated: Jun 26, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Smart Money Accumulation
None View Scanner →
Strength: 5.3/10
Get Alerted When MNKD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: MNKD shows positive signals but monitor for confirmation. Market pricing in 4.4% decline. Moderate conviction.
💡 BUY OPPORTUNITY: MNKD shows positive signals but monitor for confirmation. Market pricing in 4.4% decline. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: MNKD is currently trading at $4.14, which is considered extended relative to its 30-day fair value range of $3.32 to $3.90. From a valuation perspective, the stock is trading at a discount (Forward PE: 21.5) compared to its historical average (24.6). Remarkably, the market is currently pricing in an annual earnings decline of 4.4% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, MNKD is in a downtrend. The price is approaching resistance at $4.19. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 5.3% recently.
Market Sentiment: MNKD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $7.59 (+83.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MNKD is in a downtrend. The price is approaching resistance at $4.19. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 5.3% recently.
Market Sentiment: MNKD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $7.59 (+83.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.32 -
$3.90
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
61.9%
All Signals
- BEARISH: Price extended above range (+6.2% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.3%)
- BULLISH: Trading 83.4% below Wall St target ($7.59)
Trading Range Analysis
30-Day Trading Range
$3.32 -
$3.90
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$3.64
Resistance Level
$4.19
Current Trend
Downtrend
Technical data as of
Jun 26, 2026
Fundamental Context
Forward P/E (Next Year Est.)
21.51
Wall Street Target
$7.59
(+83.4%)
Revenue Growth (YoY)
15.1%
Earnings Growth (YoY)
-34.9%
Profit Margin
-6.6%
Valuation Discount vs History
-4.4% cheaper
PE vs Historical
21.5 vs 24.6
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.4%
(market-implied from PE analysis)
1-Year Target
$3.96
(-4%)
2-Year Target
$3.78
(-9%)
3-Year Target
$3.62
(-13%)
3-Yr Target (if PE normalizes)
(PE: 22→25)
$4.14
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 126.5%)
$14.15
(+242%)
Base:
(SPY PE: 21.5, Growth: 126.5%)
$13.97
(+238%)
Bear:
(PE: 18.3, Growth: 126.5%)
$11.88
(+187%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 21.5 to 24.6
Stabilization Target:
$4.74
(+14.4%)
PE Expansion Potential:
+14.4%
Share & Embed Analysis
Last updated: June 27, 2026 2:56 PM ET
Data refreshes hourly during market hours. Next update: 3:56 PM
Data refreshes hourly during market hours. Next update: 3:56 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MNKD showing a specific setup today?
Insider Activity (6 Months)
1
Buys
1
Sells
0
Net
INSIDERS SELLING
Recent Transactions
Michael Castagna
BUY
100000 shares
2026-03-10
Stuart A Tross
SELL
47006 shares
2026-01-08
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 51 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$31 | 62 BUY |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$122 | 56 HOLD |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
14 analysts |
$38 | 56 HOLD |
|
CNTA
Centessa Pharmaceuticals… |
STRONG BUY
11 analysts |
$44 | 61 BUY |
Advanced MNKD Option Strategies
Professional options setups generated by AI based on today's MNKD price and gamma walls.
